These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 21150165)
21. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903 [TBL] [Abstract][Full Text] [Related]
22. Developmental consequences of oxytocin. Carter CS Physiol Behav; 2003 Aug; 79(3):383-97. PubMed ID: 12954433 [TBL] [Abstract][Full Text] [Related]
23. Oxytocin plasma concentrations in children and adolescents with autism spectrum disorder: correlation with autistic symptomatology. Taurines R; Schwenck C; Lyttwin B; Schecklmann M; Jans T; Reefschläger L; Geissler J; Gerlach M; Romanos M Atten Defic Hyperact Disord; 2014 Sep; 6(3):231-9. PubMed ID: 24989441 [TBL] [Abstract][Full Text] [Related]
24. The Role of the Oxytocin/Arginine Vasopressin System in Animal Models of Autism Spectrum Disorder. Zhang R; Xu XJ; Zhang HF; Han SP; Han JS Adv Anat Embryol Cell Biol; 2017; 224():135-158. PubMed ID: 28551755 [TBL] [Abstract][Full Text] [Related]
25. The promiscuity of the oxytocin-vasopressin systems and their involvement in autism spectrum disorder. Borie AM; Theofanopoulou C; Andari E Handb Clin Neurol; 2021; 182():121-140. PubMed ID: 34266588 [TBL] [Abstract][Full Text] [Related]
26. Oxytocin, vasopressin, and human social behavior. Heinrichs M; von Dawans B; Domes G Front Neuroendocrinol; 2009 Oct; 30(4):548-557. PubMed ID: 19505497 [TBL] [Abstract][Full Text] [Related]
27. Hippocampal gene expression patterns in oxytocin male knockout mice are related to impaired social interaction. Lazzari VM; Zimmermann-Peruzatto JM; Agnes G; Becker RO; de Moura AC; Almeida S; Guedes RP; Giovenardi M Behav Brain Res; 2019 May; 364():464-468. PubMed ID: 29102591 [TBL] [Abstract][Full Text] [Related]
28. Molecular evolution of the neurohypophysial hormone precursors in mammals: Comparative genomics reveals novel mammalian oxytocin and vasopressin analogues. Wallis M Gen Comp Endocrinol; 2012 Nov; 179(2):313-8. PubMed ID: 22995712 [TBL] [Abstract][Full Text] [Related]
29. Male-specific features are reduced in Mecp2-null mice: analyses of vasopressinergic innervation, pheromone production and social behaviour. Martínez-Rodríguez E; Martín-Sánchez A; Kul E; Bose A; Martínez-Martínez FJ; Stork O; Martínez-García F; Lanuza E; Santos M; Agustín-Pavón C Brain Struct Funct; 2020 Sep; 225(7):2219-2238. PubMed ID: 32749543 [TBL] [Abstract][Full Text] [Related]
30. Neuropeptidergic regulation of affiliative behavior and social bonding in animals. Lim MM; Young LJ Horm Behav; 2006 Nov; 50(4):506-17. PubMed ID: 16890230 [TBL] [Abstract][Full Text] [Related]
31. Research review: Social motivation and oxytocin in autism--implications for joint attention development and intervention. Stavropoulos KK; Carver LJ J Child Psychol Psychiatry; 2013 Jun; 54(6):603-18. PubMed ID: 23451765 [TBL] [Abstract][Full Text] [Related]
32. Neural targets in the study and treatment of social cognition in autism spectrum disorder. Vahabzadeh A; Landino SM; Finger BC; Carlezon WA; McDougle CJ Handb Exp Pharmacol; 2015; 228():309-34. PubMed ID: 25977088 [TBL] [Abstract][Full Text] [Related]
33. Different signaling molecules responsible for IL-1beta-induced oxytocinergic and vasopressinergic neuron activation in the hypothalamic paraventricular nucleus of the rat. Wang X; Zhang XJ; Tan QR; Ju G; Wang BR Neurochem Int; 2006 Mar; 48(4):312-7. PubMed ID: 16386822 [TBL] [Abstract][Full Text] [Related]
34. Oxytocin, Vasopressin, and the Motivational Forces that Drive Social Behaviors. Caldwell HK; Albers HE Curr Top Behav Neurosci; 2016; 27():51-103. PubMed ID: 26472550 [TBL] [Abstract][Full Text] [Related]
35. Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism. Carson DS; Garner JP; Hyde SA; Libove RA; Berquist SW; Hornbeak KB; Jackson LP; Sumiyoshi RD; Howerton CL; Hannah SL; Partap S; Phillips JM; Hardan AY; Parker KJ PLoS One; 2015; 10(7):e0132224. PubMed ID: 26200852 [TBL] [Abstract][Full Text] [Related]
36. Neonatal CSF vasopressin concentration predicts later medical record diagnoses of autism spectrum disorder. Oztan O; Garner JP; Constantino JN; Parker KJ Proc Natl Acad Sci U S A; 2020 May; 117(19):10609-10613. PubMed ID: 32341146 [TBL] [Abstract][Full Text] [Related]
37. Biomarker discovery for disease status and symptom severity in children with autism. Oztan O; Jackson LP; Libove RA; Sumiyoshi RD; Phillips JM; Garner JP; Hardan AY; Parker KJ Psychoneuroendocrinology; 2018 Mar; 89():39-45. PubMed ID: 29309996 [TBL] [Abstract][Full Text] [Related]
38. Oxytocin and vasopressin: social neuropeptides with complex neuromodulatory functions. Benarroch EE Neurology; 2013 Apr; 80(16):1521-8. PubMed ID: 23589638 [No Abstract] [Full Text] [Related]
39. MDMA ('Ecstasy'), oxytocin and vasopressin modulate social preference in rats: A role for handling and oxytocin receptors. Ramos L; Hicks C; Caminer A; Couto K; Narlawar R; Kassiou M; McGregor IS Pharmacol Biochem Behav; 2016; 150-151():115-123. PubMed ID: 27725273 [TBL] [Abstract][Full Text] [Related]
40. Are retinoids potential therapeutic agents in disorders of social cognition including autism? Ebstein RP; Mankuta D; Yirmiya N; Malavasi F FEBS Lett; 2011 Jun; 585(11):1529-36. PubMed ID: 21557943 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]